Literature DB >> 15544035

Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling.

Debabrata Mukhopadhyay1, Huiyan Zeng, Resham Bhattacharya.   

Abstract

The adult vasculature results from a network of vessels that is originally derived in the embryo by vasculogenesis, a process whereby vessels are formed de novo from endothelial cell (EC) precursors, known as angioblasts. During vasculogenesis, angioblasts proliferate and come together to form an initial network of vessels, also known as the primary capillary plexus. Sprouting and branching of new vessels from the preexisting vessels in the process of angiogenesis remodel the capillary plexus. Normal angiogenesis, a well-balanced process, is important in the embryo to promote primary vascular tree as well as an adequate vasculature from developing organs. On the other hand, pathological angiogenesis which frequently occurs in tumors, rheumatoid arthritis, diabetic retinopathy and other circumstances can induce their own blood supply from the preexisting vasculature in a route that is close to normal angiogenesis. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is perhaps the most important of pro-angiogenic cytokine because of its ability to regulate most of the steps in the angiogenic cascade. The main goal of this review article is to discuss the complex nature of the mode of action of VPF/VEGF on vascular endothelium. To this end, we conclude that more research needs to be done for completely understanding the VPF/VEGF biology with relation to angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544035     DOI: 10.1023/b:mcbi.0000044374.85095.df

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  74 in total

1.  VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies.

Authors:  Ulf Eriksson; Kari Alitalo
Journal:  Nat Med       Date:  2002-08       Impact factor: 53.440

2.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy.

Authors:  S A Akhter; L M Luttrell; H A Rockman; G Iaccarino; R J Lefkowitz; W J Koch
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

3.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Authors:  H Gille; J Kowalski; B Li; J LeCouter; B Moffat; T F Zioncheck; N Pelletier; N Ferrara
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

Review 6.  Gene therapy with vascular endothelial growth factor reduces angina.

Authors:  Carrie J Merkle; David W Montgomery
Journal:  J Cardiovasc Nurs       Date:  2003 Jan-Mar       Impact factor: 2.083

7.  Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).

Authors:  Tatsuo Tanimoto; Zheng-Gen Jin; Bradford C Berk
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

Review 8.  Recent progress in gene therapy for cardiovascular disease.

Authors:  Ryuichi Morishita
Journal:  Circ J       Date:  2002-12       Impact factor: 2.993

9.  Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Eric Boersma; Andreas M Zeiher; Maarten L Simoons
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

10.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more
  12 in total

1.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Interstitial fluid flow intensity modulates endothelial sprouting in restricted Src-activated cell clusters during capillary morphogenesis.

Authors:  Rodrigo Hernández Vera; Elsa Genové; Lery Alvarez; Salvador Borrós; Roger Kamm; Douglas Lauffenburger; Carlos E Semino
Journal:  Tissue Eng Part A       Date:  2009-01       Impact factor: 3.845

3.  An atypical case of POEMS syndrome with IgG kappa M protein and end stage renal failure.

Authors:  Belda Dursun; Mehmet Artac; Halil Ibrahim Varan; Bahar Kilicarslan Akkaya; Gulten Karpuzoglu; Gultekin Suleymanlar
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

4.  Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.

Authors:  Nadine Dalrymple; Erich R Mackow
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth.

Authors:  Ding-Zhong Yang; Jing He; Ji-Cheng Zhang; Zuo-Ren Wang
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

6.  Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.

Authors:  Md Ruhul Abid; Robert J Nadeau; Katherine C Spokes; Takashi Minami; Dan Li; Shou-Ching Shih; William C Aird
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-11       Impact factor: 8.311

7.  Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2.

Authors:  Sutapa Sinha; Pawan Kumar Vohra; Resham Bhattacharya; Shamit Dutta; Shirshendu Sinha; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

8.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

9.  Novel mechanism for obesity-induced colon cancer progression.

Authors:  Janette M Birmingham; Julia V Busik; Fay M Hansen-Smith; Jenifer I Fenton
Journal:  Carcinogenesis       Date:  2009-02-12       Impact factor: 4.944

10.  POEMS Syndrome: A Report of 14 Cases and Review of the Literature.

Authors:  Zong Fei Ji; Dan Ying Zhang; Shu Qiang Weng; Xi Zhong Shen; Hou Yu Liu; Ling Dong
Journal:  ISRN Gastroenterol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.